Company Overview and News

Magnis Resources secures strategic stake in US lithium battery technology group

Magnis Resources Ltd (ASX:MNS) has made a strategic investment to acquire a 10% interest in leading US-based, lithium-ion battery technology group, Charge CCCV LLC.
Upvote Downvote

Magnis Resources purchases equipment to fast-track U.S. lithium battery plant

Magnis Resources Ltd (ASX:MNS) and partners have placed the winning bid for the acquisition of near new lithium-ion battery manufacturing equipment currently located in North Carolina, U.S.
Upvote Downvote

Magnis Resources secures New York state funding for lithium-ion gigafactory

Magnis Resources Ltd (ASX:MNS) has secured a funding package from the New York state government for its lithium-ion gigafactory to be located at Huron Campus in upstate New York.
Upvote Downvote

Magnis Resources secures funding for New York lithium-ion battery gigafactory

Magnis Resources Ltd (ASX:MNS) has received support and a funding package for the stage 1 production at New York State’s first lithium-ion gigafactory to be located at Huron Campus in upstate New York.
Upvote Downvote

Magnis Resources plans next steps for lithium-ion battery manufacturing facility in New York

Magnis Resources Ltd (ASX:MNS) is preparing to reveal details regarding government support and funding towards the lithium-ion battery manufacturing facility in New York.
Upvote Downvote

Summer Doldrums - A Trifecta Of Bad News

2017-07-07 seekingalpha
Summer seasonality is in full effect and the precious metals and the mining stocks are the weakest they've been all year.
Upvote Downvote

Magnis Resources makes progress on lithium battery gigafactory

Magnis Resources (ASX:MNS) is in the process of selecting the site for the proposed Townsville lithium-ion battery gigafactory to be built by a consortium of companies.
Upvote Downvote

Magnis Resources to reveal next plans on battery factory

Magnis Resources (ASX:MNS) has been granted a trading halt by the ASX, with its shares placed in pre-open.
Upvote Downvote

Magnis Resources locks in battery deal

Magnis Resources (ASX:MNS) has been granted a trading halt by the ASX this morning, with its shares placed in pre-open.
Upvote Downvote

Graphite Investors Beware - Prices Are About To Collapse

2017-02-21 seekingalpha
Graphite is a major component of lithium ion batteries. Growth in the li-ion battery market, driven by the move towards electric cars should lead to significant extra demand for graphite.
Upvote Downvote

Top 3 Graphite Miners To Consider

2017-01-10 seekingalpha
I wrote previously about the graphite miners back in May 2016, which you can read here. This time I intend to give investors an update on the sector, and my current top 3 graphite miners. I chose to write about this sector as it should be a beneficiary of the electric vehicle (EV), and energy storage boom, as lithium ion battery demand surges.
Upvote Downvote

Syrah Resource Is Set To Become The World's Largest Graphite Miner

2016-12-07 seekingalpha
Syrah Resources is an Australian mineral exploration company with a focus on the graphite sector. They also have exposure to vanadium, mineral sands, copper, coal, and uranium.
Upvote Downvote

Electric Vehicles Set To Electrify The Market In 2017

2016-11-10 seekingalpha
There are expected to be 6 companies by end 2017 selling long range (>150 mile) all electric EVs for under USD 37,500.
Upvote Downvote

Graphite Update: Kibaran, Magnis, Syrah, Focus And Stratmin

2016-09-18 seekingalpha
Growth in the use of lithium ion batteries, driven partly by increased production of electric vehicles will increase demand for the materials used in battery manufacturing.
Upvote Downvote

Graphite Industry Update: Newcomers Outshine The Old Guard

2016-09-18 seekingalpha
The graphite sector is bifurcating as investors reject the "old-guard" strategy of developing large graphite deposits.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

23h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...